Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

NCT07298473 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.

NCT NCT07298473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07298473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
Lead sponsor
Medtronic Cardiac Ablation Solutions
Phase
Not applicable
Overall status
Recruiting
Start date
April 8, 2026
Completion date
March 29, 2028
Enrollment
400 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), paroxysmal atrial fibrillation (paf), persistent atrial fibrillation